NeuroSense Therapeutics Ltd. (NRSNW) Financials

$0.24

south_east
-$0.09 (-27.27%)
Day's range
$0.24
Day's range
$0.45
Profit Margin
Revenue
Earnings
$0$0-$2M-$2M-$4M-$4M-$6M-$6M-$8M-$8M-$10M-$10M-$12M-$12MEarning20192019202020202021202120222022202320236%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin

NRSNW Income statement / Annual

Last year (2023), NeuroSense Therapeutics Ltd.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, NeuroSense Therapeutics Ltd.'s net income was -$10.11 M. See NeuroSense Therapeutics Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $97,000.00 $89,000.00 $3,000.00 $3,000.00 $0.00
Gross Profit -$97,000.00 -$89,000.00 -$3,000.00 -$3,000.00 $0.00
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $7.27 M $6.42 M $3.08 M $2.50 M $898,000.00
General & Administrative Expenses $4.78 M $7.14 M $2.51 M $393,000.00 $337,000.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $4.78 M $7.14 M $2.51 M $393,000.00 $337,000.00
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $10.29 M $13.55 M $5.59 M $2.89 M $1.24 M
Cost And Expenses $10.29 M $13.55 M $5.59 M $2.89 M $1.24 M
Interest Income $178,000.00 $91,000.00 $0.00 $61,000.00 $18,000.00
Interest Expense $550,000.00 $15,000.00 $1.15 M $1,000.00 $5,000.00
Depreciation & Amortization $97,000.00 $89,000.00 $3,000.00 $3,000.00 $1.24 M
EBITDA -$10.63 M -$13.38 M -$2.88 M -$2.83 M -$1.25 M
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $769,000.00 $1.21 M $1.55 M $60,000.00 $13,000.00
Income Before Tax -$11.28 M -$12.34 M -$4.04 M -$2.83 M -$1.22 M
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $0.00 -$1.14 M -$1.55 M $1,000.00 $5,000.00
Net Income -$10.11 M -$11.20 M -$2.50 M -$2.83 M -$1.23 M
Net Income Ratio 0 0 0 0 0
EPS -0.83 -0.97 -1.29 -1.46 -0.63
EPS Diluted -0.83 -0.97 -1.29 -1.46 -0.63
Weighted Average Shares Out $13.64 M $11.50 M $1.94 M $1.94 M $1.94 M
Weighted Average Shares Out Diluted $13.64 M $11.50 M $1.94 M $1.94 M $1.94 M
Link